Miquel Tuson
Overview
Explore the profile of Miquel Tuson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
565
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Villanueva-Mendoza C, Tuson M, Apam-Garduno D, de Castro-Miro M, Tonda R, Trotta J, et al.
Genes (Basel)
. 2021 Nov;
12(11).
PMID: 34828430
In this work, we aimed to provide the genetic diagnosis of a large cohort of patients affected with inherited retinal dystrophies (IRDs) from Mexico. Our data add valuable information to...
2.
Anmella G, Vilches S, Espadaler-Mazo J, Murru A, Pacchiarotti I, Tuson M, et al.
Genes (Basel)
. 2021 Aug;
12(8).
PMID: 34440433
Several pharmacogenetic-based decision support tools for psychoactive medication selection are available. However, the scientific evidence of the gene-drug pairs analyzed is mainly based on pharmacogenetic studies in patients with major...
3.
Gonzalez-Duarte R, de Castro-Miro M, Tuson M, Ramirez-Castaneda V, Gils R, Marfany G
Adv Exp Med Biol
. 2019 Dec;
1185:215-219.
PMID: 31884614
During the last 20 years, our group has focused on identifying the genes and mutations causative of inherited retinal dystrophies (IRDs). By applying massive sequencing approaches (NGS) in more than...
4.
Vilches S, Tuson M, Vieta E, Alvarez E, Espadaler J
Pharmaceutics
. 2019 Sep;
11(9).
PMID: 31480800
Several pharmacogenetic tests to support drug selection in psychiatric patients have recently become available. The current meta-analysis aimed to assess the clinical utility of a commercial pharmacogenetic-based tool for psychiatry...
5.
Ielmini M, Poloni N, Caselli I, Espadaler J, Tuson M, Grecchi A, et al.
Pharmgenomics Pers Med
. 2018 Mar;
11:35-42.
PMID: 29588611
Background: Bipolar disorder (BD) is a frequent cause of disability, health care costs, and risk of suicide. Pharmacogenetic tests (PGTs) could help clinicians to identify those patients predisposed to the...
6.
Perez V, Salavert A, Espadaler J, Tuson M, Saiz-Ruiz J, Saez-Navarro C, et al.
BMC Psychiatry
. 2017 Jul;
17(1):250.
PMID: 28705252
Background: A 12-week, double-blind, parallel, multi-center randomized controlled trial in 316 adult patients with major depressive disorder (MDD) was conducted to evaluate the effectiveness of pharmacogenetic (PGx) testing for drug...
7.
Espadaler J, Tuson M, Lopez-Ibor J, Lopez-Ibor F, Lopez-Ibor M
CNS Spectr
. 2016 Apr;
22(4):315-324.
PMID: 27098095
Objective: We investigated the association between clinical outcome and the recommendations of a pharmacogenetic test (Neuropharmagen) in patients with a variety of psychiatric conditions whose previous treatment regimen had failed....
8.
Tuson M, He M, Anderson K
Development
. 2011 Oct;
138(22):4921-30.
PMID: 22007132
Protein kinase A (PKA) is an evolutionarily conserved negative regulator of the hedgehog (Hh) signal transduction pathway. PKA is known to be required for the proteolytic processing event that generates...
9.
Ocbina P, Tuson M, Anderson K
PLoS One
. 2009 Sep;
4(8):e6839.
PMID: 19718259
Background: Sonic hedgehog (Shh) signaling in the mouse requires the microtubule-based organelle, the primary cilium. The primary cilium is assembled and maintained through the process of intraflagellar transport (IFT) and...
10.
Tuson M, Garanto A, Gonzalez-Duarte R, Marfany G
Mol Vis
. 2009 Jan;
15:168-80.
PMID: 19158957
Purpose: Retinitis pigmentosa (RP), a retinal neurodegenerative disorder characterized by apoptosis of photoreceptor cells, is caused by mutations in many different genes. We analyzed the RP gene ceramide kinase-like (CERKL)...